Gentamicin Sulfate Prices June 2023
Product
|
Category |
Region |
Price |
Gentamicin Sulfate |
Pharma API |
USA |
145172 USD/MT |
Gentamicin Sulfate |
Pharma API |
China |
112400 USD/MT |
Gentamicin Sulfate |
Pharma API |
Germany |
158560 USD/MT |
The price of gentamicin sulfate in the USA for Q2 2023 reached 145172 USD/MT in June 2023.
The price of gentamicin sulfate in China for Q2 2023 reached 112400 USD/MT in June 2023.
The price of gentamicin sulfate in Germany for Q2 2023 reached 158560 USD/MT in June 2023.
Gentamicin Sulfate Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Gentamicin Sulfate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of gentamicin sulfate pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of gentamicin sulfate at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of gentamicin sulfate price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing gentamicin sulfate price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Gentamicin Sulfate Market Analysis
The global gentamicin sulfate market size reached US$ 524.2 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 691.1 Million, at a projected CAGR of 3.12% during 2023-2032.
- One of the primary factors driving the market growth is the widespread product adoption in the treatment of complicated urinary tract infections (UTIs). Through its potent action against gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa, gentamicin sulfate is often administered when other antibiotics may not be effective. Its rapid bactericidal activity helps in quickly reducing bacterial load and alleviating the symptoms associated with severe UTIs, making it a critical option in urological therapy.
- Gentamicin sulfate is also utilized in the treatment of bone and joint infections, such as osteomyelitis and septic arthritis, which are often challenging to treat due to the difficulty of antibiotic penetration into bone tissue. This is contributing to the market expansion.
- Moreover, the global rise in healthcare expenditure is driving the demand for effective antibiotics like gentamicin sulfate. As countries invest more in healthcare infrastructure and services, the accessibility and utilization of antibiotics for treating severe infections are expected to increase. This rise in healthcare spending correlates with better diagnostic facilities and increased healthcare awareness, leading to a higher prescription rate of gentamicin sulfate for appropriate indications.
- Gentamicin sulfate has a broad spectrum of antibacterial activity, making it effective against a wide range of gram-negative and some gram-positive bacteria. Additionally, its rapid onset of action allows for a quick reduction in bacterial load, which is crucial in severe and life-threatening infections, thereby aiding in market expansion.
- Moreover, gentamicin sulfate is often used in combination with other antibiotics to enhance its efficacy and prevent bacterial resistance, which further provides an impetus to the market growth.
- Besides this, the veterinary medicine sector also represents a significant driver for the gentamicin sulfate market. The use of this antibiotic in treating bacterial infections in animals is widespread, particularly in livestock and poultry. The health of these animals directly impacts food safety and productivity, making effective antibiotics like gentamicin sulfate essential in the livestock sector, thus bolstering the market growth.
Gentamicin Sulfate News
The report covers the latest developments, updates, and trends impacting the global gentamicin sulfate market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in gentamicin sulfate production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the gentamicin sulfate price trend.
Latest developments in the gentamicin sulfate industry:
- In April 2024, Suanfarma addressed supply chain challenges by integrating hybrid fermentation and chemical synthesis in their production processes. This method enhances the efficiency and scalability of producing APIs, including gentamicin sulfate, ensuring a more reliable supply chain and consistent product quality.
- In March 2024, the FDA approved two Sandoz biosimilars for two blockbuster Amgen bone drugs, Prolia and Xgeva. Prolia is marketed for osteoporosis, while Xgeva is used to prevent bone problems in multiple myeloma patients and solid tumors. Sandoz's biosimilar for osteoporosis will be called Jubbonti, while Wyost will be marketed for cancer.
Product Description
Gentamicin sulfate is an aminoglycoside antibiotic derived from Micromonospora purpurea, a type of actinobacteria. It is commonly used to treat a variety of bacterial infections. The compound is typically available in the form of a white to off-white powder that is soluble in water. As an aminoglycoside, gentamicin sulfate works by inhibiting bacterial protein synthesis, which ultimately leads to the death of susceptible bacteria.
It is widely used in both human and veterinary medicine due to its broad-spectrum antibacterial properties. In human medicine, it is often employed to treat severe infections such as septicemia, respiratory tract infections, urinary tract infections (UTIs), and infections of the bones and joints. Additionally, gentamicin sulfate is frequently used in combination with other antibiotics to enhance its effectiveness and broaden the scope of bacterial coverage.
Regional Coverage
The report provides a detailed analysis of the gentamicin sulfate market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the gentamicin sulfate price trend.
Global Gentamicin Sulfate Price
The report offers a holistic view of the global gentamicin sulfate pricing trends in the form of gentamicin sulfate price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of gentamicin sulfate but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed gentamicin sulfate demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Gentamicin Sulfate Price
European gentamicin sulfate prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed gentamicin sulfate price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Gentamicin Sulfate Price
The analysis of gentamicin sulfate prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific gentamicin sulfate historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Gentamicin Sulfate Price
The report explores the gentamicin sulfate pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on gentamicin sulfate prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Gentamicin Sulfate Price
The gentamicin sulfate pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This gentamicin sulfate price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Gentamicin Sulfate Price
The analysis of gentamicin sulfate prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Gentamicin Sulfate |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Gentamicin Sulfate Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of gentamicin sulfate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting gentamicin sulfate price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The gentamicin sulfate price charts ensure our clients remain at the forefront of the industry.